vimarsana.com
Home
Live Updates
Aptorum Group Limited Reports Financial Results and Business
Aptorum Group Limited Reports Financial Results and Business
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Singapore ,
San Diego ,
California ,
Darren Lui ,
Clark Cheng ,
Ian Huen ,
Drug Administration ,
Aptorum Group Limited Nasdaq ,
Company Classa Ordinary ,
Pathsdx Group ,
Aptorum Group Limited ,
Aptorum Therapeutics Limited ,
Technology Corporation ,
Idx Technology ,
Jurchen Investment Corporation ,
Technologies Pte Ltd ,
Singapore Agency For Science ,
Daptorum Group ,
Aptorum Group Form ,
Paths Innovation ,
Chief Executive Officer ,
Executive Director ,
Pipeline Update ,
Methicillin Resistant Staphylococcus Aureus ,
Acute Bacterial Skin ,
Skin Structure Infections ,
Grand Cayman Islands ,
Term Sheet ,
Paths Innovation Limited ,
Universal Sequencing Technology Corporation ,
Innovation Limited ,
Paths Diagnostics ,
Ordinary Shares ,
Chief Executive ,
Six Months Ended June ,
Group Limited ,
Accelerate Technologies Pte Ltd ,
Securities Litigation Reform Act ,